Literature DB >> 25542296

Protective effects of melatonin against oxidative damage induced by Egyptian cobra (Naja haje) crude venom in rats.

Ahmed E Abdel Moneim1, Francisco Ortiz2, Roberto C Leonardo-Mendonça2, Roberto Vergano-Villodres2, Jose Antonio Guerrero-Martínez2, Luis C López3, Darío Acuña-Castroviejo4, Germaine Escames5.   

Abstract

Naja haje envenomation is one of the leading causes of death due to snakebite. Antiserum therapy sometimes fails to provide enough protection against venom toxicity. In this study, we investigated the protective effects of melatonin against N. haje venom in rats. The animals were injected with venom (0.25mg/kg) and/or melatonin (10mg/kg) and compared with vehicle-treated rats. There was oxidative/nitrosative damage and apoptosis in the liver, heart, and kidneys of venom-injected rats. Melatonin counteracted the increased lipoperoxidation and nitric oxide, prevented decreased glutathione peroxidase and reductase activity, reduced the glutathione disulfide/glutathione (GSSG/GSH) ratio, and maintained the GSH pool. Furthermore, melatonin administration was associated with a reduction of apoptosis, which was increased in venom-injected rats. Overall, these results suggest that melatonin mitigates oxidative/nitrosative stress in venom-induced cardio-hepato-renal injury in rats. Our results suggest that melatonin treatment may ameliorate some of the effects of N. haje envenomation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Melatonin; Naja haje venom; Oxidative damage

Mesh:

Substances:

Year:  2014        PMID: 25542296     DOI: 10.1016/j.actatropica.2014.12.007

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  8 in total

1.  The protective properties of melatonin against aluminium-induced neuronal injury.

Authors:  Ebtesam M Al-Olayan; Manal F El-Khadragy; Ahmed E Abdel Moneim
Journal:  Int J Exp Pathol       Date:  2015-04-19       Impact factor: 1.925

Review 2.  Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.

Authors:  Vaibhav Walia; Deepak Kaushik; Vineet Mittal; Kuldeep Kumar; Ravinder Verma; Jatin Parashar; Rokeya Akter; Md Habibur Rahman; Saurabh Bhatia; Ahmed Al-Harrasi; Chenmala Karthika; Tanima Bhattacharya; Hitesh Chopra; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2021-11-09       Impact factor: 5.682

Review 3.  Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas.

Authors:  Russel J Reiter; Sergio Rosales-Corral; Dun Xian Tan; Mei Jie Jou; Annia Galano; Bing Xu
Journal:  Cell Mol Life Sci       Date:  2017-09-01       Impact factor: 9.261

Review 4.  Oral Mucositis: Melatonin Gel an Effective New Treatment.

Authors:  Ahmed Esmat Abdel Moneim; Ana Guerra-Librero; Javier Florido; Ying-Qiang Shen; Beatriz Fernández-Gil; Darío Acuña-Castroviejo; Germaine Escames
Journal:  Int J Mol Sci       Date:  2017-05-07       Impact factor: 5.923

Review 5.  Oxidant/Antioxidant imbalance and the risk of Alzheimer's disease.

Authors:  Ahmed E Abdel Moneim
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 6.  Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3.

Authors:  Russel J Reiter; Dun Xian Tan; Sergio Rosales-Corral; Annia Galano; Mei-Jie Jou; Dario Acuna-Castroviejo
Journal:  Int J Mol Sci       Date:  2018-08-18       Impact factor: 5.923

7.  The Protective Effects of Melatonin on Aluminum-Induced Hepatotoxicity and Nephrotoxicity in Rats.

Authors:  Mohamed S Othman; Mohamed A Fareid; Reda S Abdel Hameed; Ahmed E Abdel Moneim
Journal:  Oxid Med Cell Longev       Date:  2020-10-19       Impact factor: 6.543

Review 8.  Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection.

Authors:  Russel J Reiter; Ramaswamy Sharma; Fedor Simko; Alberto Dominguez-Rodriguez; Jan Tesarik; Richard L Neel; Andrzej T Slominski; Konrad Kleszczynski; Verna M Martin-Gimenez; Walter Manucha; Daniel P Cardinali
Journal:  Cell Mol Life Sci       Date:  2022-02-20       Impact factor: 9.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.